Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Luteal Phase Support With Vaginal Progesterone on the Clinical Pregnancy Rate in Intrauterine Insemination Cycles Stimulated With Gonadotrophins: a Prospective Randomized Multicentre Study.
Brief Summary: The objective is to test the hypothesis that luteal phase support with vaginal progesterone leads to a higher clinical pregnancy rate (primary outcome) and live birth rate (secondary outcome) when compared to no luteal phase support in a program of intrauterine insemination (IUI) after controlled ovarian stimulation with gonadotrophins. Additionally, the length of the luteal phase will be recorded (secondary outcome) in order to detect luteal phase defects/insufficiencies in the absence of luteal phase suppletion as well as luteal phase prolongation in case of luteal phase support which may be a burden for the patients waiting for the outcome of the treatment.


Options:
A: Arm Label: micronized progesterone; Type: EXPERIMENTAL; Interventions: Drug: micronized progesterone | Arm Label: no utrogestan; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: micronized progesterone; Assigned to Arm(s): micronized progesterone
B: Arm Label: Menotropin/Progesterone vaginal insert; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone vaginal insert, Drug: leuprolide acetate | Arm Label: Menotropin/Progesterone in oil; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone in oil, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone vaginal insert; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone vaginal insert, Drug: Follitropin beta, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone in oil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin beta, Drug: Progesterone in oil, Drug: leuprolide acetate | Intervention Type: DRUG; Name: Menotropin; Assigned to Arm(s): Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone vaginal insert; Assigned to Arm(s): Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Follitropin beta; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone in oil; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Menotropin/Progesterone in oil | Intervention Type: DRUG; Name: leuprolide acetate; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert
C: Arm Label: experimental; Type: EXPERIMENTAL; Interventions: Drug: crinone (progesterone 8%, vaginal application) | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: crinone (progesterone 8%, vaginal application); Assigned to Arm(s): experimental
D: Arm Label: Endometrial biopsy arm; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial biopsy, Device: Transvaginal ultrasound | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): Endometrial biopsy arm | Intervention Type: DEVICE; Name: Transvaginal ultrasound; Assigned to Arm(s): Endometrial biopsy arm

Answer: C